These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17149360)

  • 1. Intravenous immunoglobulin (IVIG).
    Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):101-3. PubMed ID: 17149360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of immunoglobulin in the therapy of neurological illnesses].
    Elovaara I; Färkkilä M; Hietaharju A; Pirttilä T
    Duodecim; 2001; 117(10):1033-41; quiz 1041, 1081. PubMed ID: 12116461
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions.
    Robinson P; Anderson D; Brouwers M; Feasby TE; Hume H;
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S3-8. PubMed ID: 17397767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins in neurological diseases.
    Zettl UK; Mix E
    J Neurol; 2006 Sep; 253 Suppl 5():V1. PubMed ID: 16998748
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 7. The nurse's role in administration of intravenous immunoglobulin therapy.
    Kirmse J
    Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the commercial type of IVIG used make a difference?
    Haque KH
    Pediatrics; 1992 Apr; 89(4 Pt 2):806-7. PubMed ID: 1557295
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current clinical uses of intravenous immunoglobulin.
    El-Shanawany T; Sewell WA; Misbah SA; Jolles S
    Clin Med (Lond); 2006; 6(4):356-9. PubMed ID: 16956140
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions.
    Hume HA; Anderson DR
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S1-2. PubMed ID: 17397766
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
    Rey JB; Luria RB
    J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can we do without intravenous polyclonal immunoglobines (IVIg)?].
    Gary-Crosier F; Nydegger U; Villard J
    Rev Med Suisse; 2009 Apr; 5(199):819-22. PubMed ID: 19441747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomics of intravenous immunoglobulin in various neurological disorders.
    Tsai CP
    Acta Neurol Taiwan; 2010 Dec; 19(4):303-8. PubMed ID: 21234830
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical decisions in selecting an intravenous immunoglobulin product.
    Gelfand EW
    J Infus Nurs; 2005; 28(6):366-74. PubMed ID: 16304494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
    Gold R; Stangel M; Dalakas MC
    Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
    Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Wang N; Zhu KY; Brenner T; Laub O; Souroujon MC
    J Neuroimmunol; 2008 Feb; 194(1-2):89-96. PubMed ID: 18178258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.